Marksans Pharma share price
NSE: MARKSANS · Biotechnology & Drugs
₹315.3 +0.96%
Data as of 2026-11-03 (NSE close)
1-year price chart
Key ratios
Market cap
₹14,038 Cr
P/E
23.90x
P/B
4.61x
ROE
16.6%
ROCE
n/a
Debt / Equity
0.11
Dividend yield
0.29%
52W high / low
₹350.95 / ₹155
Latest Marksans Pharma news
Marksans Pharma Board Meeting for Quarterly Earnings · NSE India 2026-08-10
Marksans Pharma Limited Schedules Dividend with August Ex-Date · Trendlyne 2026-08-06
Marksans Pharma Q1 Net Profit Jumps 25% on Strong US and UK Sales · Economic Times 2026-07-27
Marksans Pharma Subsidiary Gets UK Approval for Allergy Solution · 2025-11-20
Marksans Pharma’s Arm Gets USFDA’s Final Nod for Loperamide Hydrochloride Tablets · 2025-11-19
Biotechnology & Drugs peers
AI analysis
Sign up free to see the full analysis
Quantsgrow scorecard
Sign up free to see the full analysis